Aileron Therapeutics Cash from Financing (TTM) Trends

Aileron Therapeutics Inc (ALRN)

3.95 +0.19 (+5.05%) USD | NASDAQ | May 06, 16:00

3.95 0.00 (0.00%) After-Hours: 20:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2016. Upgrade now.

Date	Value
December 31, 2023	15.79M
September 30, 2023	0.00
June 30, 2023	0.00
March 31, 2023	0.00
December 31, 2022	0.00
September 30, 2022	0.001M
June 30, 2022	0.027M
March 31, 2022	0.053M
December 31, 2021	55.66M
September 30, 2021	59.90M
June 30, 2021	60.17M
March 31, 2021	71.40M
December 31, 2020	15.80M
September 30, 2020	11.54M
June 30, 2020	11.19M

Date	Value
March 31, 2020	23.80M
December 31, 2019	23.96M
September 30, 2019	25.26M
June 30, 2019	26.52M
March 31, 2019	2.664M
December 31, 2018	2.515M
September 30, 2018	0.994M
June 30, 2018	50.49M
March 31, 2018	50.04M
December 31, 2017	50.59M
September 30, 2017	69.80M
June 30, 2017	19.10M
March 31, 2017	19.47M
December 31, 2016	31.99M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

Minimum

Dec 2022

71.40M

Maximum

Mar 2021

21.11M

Average

15.79M

Median

Dec 2023

Cash from Financing (TTM) Benchmarks